Among the 11 patients that showed GFPT2 expression in the primary tumor, 64% (n = 7) demonstrated concordant expression of GFPT2 in at least one metastatic tumor (Fig. 1f). This evidence concerns the gene GFPT2 and metastatic neoplasm.